The 2013 USPSTF statement recommends that women who have family members with breast, ovarian, tubal, or peritoneal cancer should be screened in a primary care setting using 1 of several screening tools (average sensitivity ~85%)

Screening tools are used to identify a family history suspicious for a BRCA1/2 mutation or a possible hereditary cancer predisposition syndrome (eg, Cowden syndrome); Screening results determine if a referral for genetic counseling is warranted; in certain high-risk groups (eg, Ashkenazi Jewish heritage), screening can be skipped and patients are directly referred for a genetic consult

(USPSTF 2013)

MALIGNANT BREAST DISORDERS:

Genetic Screening